These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 28459369)
1. Grainyhead-like 2 in development and cancer. Ma L; Yan H; Zhao H; Sun J Tumour Biol; 2017 May; 39(5):1010428317698375. PubMed ID: 28459369 [TBL] [Abstract][Full Text] [Related]
3. Expression of transcription factor grainyhead-like 2 is diminished in cervical cancer. Torres-Reyes LA; Alvarado-Ruiz L; Piña-Sánchez P; Martínez-Silva MG; Ramos-Solano M; Olimón-Andalón V; Ortiz-Lazareno PC; Hernández-Flores G; Bravo-Cuellar A; Aguilar-Lemarroy A; Jave-Suarez LF Int J Clin Exp Pathol; 2014; 7(11):7409-18. PubMed ID: 25550776 [TBL] [Abstract][Full Text] [Related]
4. Grainyhead-like Protein 2: The Emerging Role in Hormone-Dependent Cancers and Epigenetics. Reese RM; Harrison MM; Alarid ET Endocrinology; 2019 May; 160(5):1275-1288. PubMed ID: 30958537 [TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of Grainyhead-like epithelial transactivator (GET-1), a novel mammalian Grainyhead-like factor. Kudryavtseva EI; Sugihara TM; Wang N; Lasso RJ; Gudnason JF; Lipkin SM; Andersen B Dev Dyn; 2003 Apr; 226(4):604-17. PubMed ID: 12666198 [TBL] [Abstract][Full Text] [Related]
6. Grainyhead-like 2 downstream targets act to suppress epithelial-to-mesenchymal transition during neural tube closure. Ray HJ; Niswander LA Development; 2016 Apr; 143(7):1192-204. PubMed ID: 26903501 [TBL] [Abstract][Full Text] [Related]
7. Grainyhead-like 2 as a double-edged sword in development and cancer. He J; Feng C; Zhu H; Wu S; Jin P; Xu T Am J Transl Res; 2020; 12(2):310-331. PubMed ID: 32194886 [TBL] [Abstract][Full Text] [Related]
8. TFCP2/TFCP2L1/UBP1 transcription factors in cancer. Kotarba G; Krzywinska E; Grabowska AI; Taracha A; Wilanowski T Cancer Lett; 2018 Apr; 420():72-79. PubMed ID: 29410248 [TBL] [Abstract][Full Text] [Related]
9. Grainyhead-like (Grhl) Target Genes in Development and Cancer. Gasperoni JG; Fuller JN; Darido C; Wilanowski T; Dworkin S Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269877 [TBL] [Abstract][Full Text] [Related]
10. Grhl3 induces human epithelial tumor cell migration and invasion via downregulation of E-cadherin. Zhao P; Guo S; Tu Z; Di L; Zha X; Zhou H; Zhang X Acta Biochim Biophys Sin (Shanghai); 2016 Mar; 48(3):266-74. PubMed ID: 26837418 [TBL] [Abstract][Full Text] [Related]
11. Recent discoveries concerning the involvement of transcription factors from the Grainyhead-like family in cancer. Mlacki M; Kikulska A; Krzywinska E; Pawlak M; Wilanowski T Exp Biol Med (Maywood); 2015 Nov; 240(11):1396-401. PubMed ID: 26069269 [TBL] [Abstract][Full Text] [Related]
12. Regulation of Epithelial Cell Proliferation, Differentiation, and Plasticity by Grainyhead-Like 2 During Oral Carcinogenesis. Kang MK; Chen W; Park NH Crit Rev Oncog; 2018; 23(3-4):201-217. PubMed ID: 30311575 [TBL] [Abstract][Full Text] [Related]
13. The effect of Pokemon on bladder cancer epithelial-mesenchymal transition. Guo C; Zhu K; Sun W; Yang B; Gu W; Luo J; Peng B; Zheng J Biochem Biophys Res Commun; 2014 Jan; 443(4):1226-31. PubMed ID: 24393848 [TBL] [Abstract][Full Text] [Related]
14. TFCP2 as a therapeutic nexus: unveiling molecular signatures in cancer. Kaushik N; Jaiswal A; Bhartiya P; Choi EH; Kaushik NK Cancer Metastasis Rev; 2024 Sep; 43(3):959-975. PubMed ID: 38451384 [TBL] [Abstract][Full Text] [Related]
15. Grainyhead-like 2 inhibits the coactivator p300, suppressing tubulogenesis and the epithelial-mesenchymal transition. Pifer PM; Farris JC; Thomas AL; Stoilov P; Denvir J; Smith DM; Frisch SM Mol Biol Cell; 2016 Aug; 27(15):2479-92. PubMed ID: 27251061 [TBL] [Abstract][Full Text] [Related]
16. Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma. Wang YP; Guo PT; Zhu Z; Zhang H; Xu Y; Chen YZ; Liu F; Ma SP Oncol Rep; 2017 Apr; 37(4):1961-1970. PubMed ID: 28259923 [TBL] [Abstract][Full Text] [Related]
17. A Grainyhead-Like 2/Ovo-Like 2 Pathway Regulates Renal Epithelial Barrier Function and Lumen Expansion. Aue A; Hinze C; Walentin K; Ruffert J; Yurtdas Y; Werth M; Chen W; Rabien A; Kilic E; Schulzke JD; Schumann M; Schmidt-Ott KM J Am Soc Nephrol; 2015 Nov; 26(11):2704-15. PubMed ID: 25788534 [TBL] [Abstract][Full Text] [Related]
18. Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition. Xu Y; Ma YH; Pang YX; Zhao Z; Lu JJ; Mao HL; Liu PS Tumour Biol; 2017 May; 39(5):1010428317701627. PubMed ID: 28475014 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin. Shah P; Gau Y; Sabnis G Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977 [TBL] [Abstract][Full Text] [Related]
20. NKX6.1 functions as a metastatic suppressor through epigenetic regulation of the epithelial-mesenchymal transition. Li HJ; Yu PN; Huang KY; Su HY; Hsiao TH; Chang CP; Yu MH; Lin YW Oncogene; 2016 Apr; 35(17):2266-78. PubMed ID: 26257059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]